scholarly journals Experience of follow-up, quality of life, and transition from pediatric to adult healthcare of patients with tuberous sclerosis complex

2019 ◽  
Vol 96 ◽  
pp. 23-27 ◽  
Author(s):  
Claire Bar ◽  
Rouba Ghobeira ◽  
Rita Azzi ◽  
Dorothée Ville ◽  
Audrey Riquet ◽  
...  
Brain ◽  
2020 ◽  
Vol 143 (2) ◽  
pp. 570-581 ◽  
Author(s):  
Shiyong Liu ◽  
Tao Yu ◽  
Yuguang Guan ◽  
Kai Zhang ◽  
Ping Ding ◽  
...  

Abstract At least 50% of patients with tuberous sclerosis complex present with intractable epilepsy; for these patients, resective surgery is a treatment option. Here, we report a nationwide multicentre retrospective study and analyse the long-term seizure and neuropsychological outcomes of epilepsy surgery in patients with tuberous sclerosis complex. There were 364 patients who underwent epilepsy surgery in the study. Patients’ clinical data, postoperative seizure outcomes at 1-, 4-, and 10-year follow-ups, preoperative and postoperative intelligence quotients, and quality of life at 1-year follow-up were collected. The patients’ ages at surgery were 10.35 ± 7.70 years (range: 0.5–47). The percentage of postoperative seizure freedom was 71% (258/364) at 1-year, 60% (118/196) at 4-year, and 51% (36/71) at 10-year follow-up. Influence factors of postoperative seizure freedom were the total removal of epileptogenic tubers and the presence of outstanding tuber on MRI at 1- and 4-year follow-ups. Furthermore, monthly seizure (versus daily seizure) was also a positive influence factor for postoperative seizure freedom at 1-year follow-up. The presence of an outstanding tuber on MRI was the only factor influencing seizure freedom at 10-year follow-up. Postoperative quality of life and intelligence quotient improvements were found in 43% (112/262) and 28% (67/242) of patients, respectively. Influence factors of postoperative quality of life and intelligence quotient improvement were postoperative seizure freedom and preoperative low intelligence quotient. The percentage of seizure freedom in the tuberectomy group was significantly lower compared to the tuberectomy plus and lobectomy groups at 1- and 4-year follow-ups. In conclusion, this study, the largest nationwide multi-centre study on resective epilepsy surgery, resulted in improved seizure outcomes and quality of life and intelligence quotient improvements in patients with tuberous sclerosis complex. Seizure freedom was often achieved in patients with an outstanding tuber on MRI, total removal of epileptogenic tubers, and tuberectomy plus. Quality of life and intelligence quotient improvements were frequently observed in patients with postoperative seizure freedom and preoperative low intelligence quotient.


2019 ◽  
Vol 23 (6) ◽  
pp. 801-807 ◽  
Author(s):  
Sam Amin ◽  
Andrew A. Mallick ◽  
Andrew Lux ◽  
Finbar O'Callaghan

2019 ◽  
Vol 4 (4) ◽  
pp. 581-592 ◽  
Author(s):  
Menno Vergeer ◽  
Wendela L. Ranitz‐Greven ◽  
Maureen P. Neary ◽  
Raluca Ionescu‐Ittu ◽  
Bruno Emond ◽  
...  

2011 ◽  
Vol 20 (3) ◽  
pp. 561-565 ◽  
Author(s):  
Jonathan Roth ◽  
Adeolu Olasunkanmi ◽  
William S. MacAllister ◽  
Emily Weil ◽  
Catherine C. Uy ◽  
...  

2017 ◽  
Vol 2017 ◽  
pp. 1-6 ◽  
Author(s):  
S. Amin ◽  
A. Lux ◽  
A. Khan ◽  
F. O’Callaghan

Background. Facial angiofibromas affect most patients with tuberous sclerosis complex. They tend to progress, can cause recurrent bleeding and facial disfigurement, and have significant psychological effects. We reviewed the effectiveness and safety of topical sirolimus ointment 0.1%. We also assessed the effect of treatment on quality of life. Methods. We report our experience in using sirolimus ointment in 14 patients with TSC (9 children and 5 adults). The impact of sirolimus ointment was monitored with digital photography, dermatological review using a validated Facial Angiofibroma Severity Index (FASI), and quality of life assessments using the questionnaires PedsQL for children and SF36 for adults. Results. The FASI scores were improved in 12/14 cases after six months’ treatment, and improvement was more likely in children (median FASI scores of improvement after treatment were 3 points for children and 1 for adults). Proxy-reported PedsQL scores for the total psychosocial domain improved significantly in the children in the cohort with treatment. Conclusions. Sirolimus ointment 0.1% administered once a day was effective in treating facial angiofibromas. It appears to be safe and well tolerated and to have a positive impact on patients’ quality of life. It appeared to be most beneficial when started in childhood.


2019 ◽  
Vol 92 ◽  
pp. 213-220 ◽  
Author(s):  
Theo Tritton ◽  
Bryan Bennett ◽  
Elaine Brohan ◽  
Laura Grant ◽  
Alison Cooper ◽  
...  

2020 ◽  
Vol 11 ◽  
Author(s):  
Anna C. Jansen ◽  
Stephanie Vanclooster ◽  
Petrus J. de Vries ◽  
Carla Fladrowski ◽  
Guillaume Beaure d'Augères ◽  
...  

2017 ◽  
Vol 32 (suppl_3) ◽  
pp. iii110-iii110
Author(s):  
Maureen Neary ◽  
Francis Vekeman ◽  
Raluca Ionescu-Ittu ◽  
Bruno Emond ◽  
Mei Duh ◽  
...  

2018 ◽  
Vol 124 (3) ◽  
pp. 176-183 ◽  
Author(s):  
Anna Maria Ierardi ◽  
Mario Petrillo ◽  
Andrea Coppola ◽  
Salvatore Alessio Angileri ◽  
Andrea Galassi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document